Isabelle Riviere Selected Research

HLA Antigens (Human Leukocyte Antigens)

11/2007

Safety and immunogenicity of tyrosinase DNA vaccines in patients with melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Isabelle Riviere Research Topics

Disease

12	Neoplasms (Cancer) 03/2024 - 04/2003
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2019 - 03/2013
4	beta-Thalassemia (Cooley's Anemia) 04/2016 - 01/2005
3	Lymphoma (Lymphomas) 01/2023 - 09/2006
3	Anemia 04/2016 - 01/2005
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 08/2013
2	Cytokine Release Syndrome 01/2019 - 02/2014
2	Multiple Myeloma 01/2019 - 01/2018
2	Sickle Cell Anemia (Hemoglobin S Disease) 04/2016 - 11/2008
2	Melanoma (Melanoma, Malignant) 11/2007 - 04/2003
1	cell-associated neurotoxicity 01/2023
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2023
1	Neurotoxicity Syndromes (Toxic Encephalopathy) 01/2023
1	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Fever (Fevers) 01/2019
1	Spinal Cord Compression 01/2019
1	Disease Progression 01/2019
1	Philadelphia Chromosome 02/2014
1	Residual Neoplasm 03/2013
1	Thalassemia 01/2011
1	Autoimmune Diseases (Autoimmune Disease) 12/2009
1	Infections 12/2009
1	Leukemia 09/2006
1	Human Influenza (Influenza) 01/2005
1	Hemoglobinopathies 01/2005
1	Herpes Simplex 04/2003

Drug/Important Bio-Agent (IBA)

9	Chimeric Antigen ReceptorsIBA 01/2023 - 02/2010
3	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2019 - 01/2018
3	B-Cell Maturation AntigenIBA 01/2019 - 01/2018
3	beta-Globins (beta Globin)IBA 04/2016 - 01/2005
3	CytokinesIBA 02/2014 - 02/2010
3	GlobinsIBA 01/2011 - 01/2005
3	HLA-A*02:01 antigenIBA 11/2007 - 01/2005
2	Hemoglobins (Hemoglobin)IBA 11/2008 - 01/2005
2	DNA (Deoxyribonucleic Acid)IBA 11/2007 - 04/2003
2	Monophenol Monooxygenase (Tyrosinase)IBA 11/2007 - 04/2003
2	fialuridineIBA 09/2006 - 04/2003
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2023
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2023
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2019
1	SteroidsIBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	CD19-specific chimeric antigen receptorIBA 01/2018
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 02/2014
1	CD19 AntigensIBA 02/2014
1	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2014
1	Interleukin-2 (IL2)IBA 08/2013
1	Indicators and Reagents (Reagents)IBA 12/2009
1	AutoantigensIBA 11/2007
1	Differentiation AntigensIBA 11/2007
1	VaccinesIBA 11/2007
1	HLA Antigens (Human Leukocyte Antigens)IBA 11/2007
1	DNA VaccinesIBA 11/2007
1	UracilIBA 09/2006
1	ThymidineIBA 09/2006
1	EpitopesIBA 01/2005
1	Peptides (Polypeptides)IBA 01/2005
1	Thymidine KinaseIBA 04/2003

Therapy/Procedure

5	Therapeutics 01/2018 - 11/2008
3	Immunotherapy 03/2024 - 04/2008
1	Transjugular Intrahepatic Portasystemic Shunt 11/2022
1	Radiotherapy 01/2019
1	Drug Therapy (Chemotherapy) 03/2013
1	Hematopoietic Stem Cell Transplantation 03/2013
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 11/2008
1	Injections 11/2007
1	Transplantation 09/2006